ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • J Mol Pharm Org Process Res 2025, Vol 13(3): 285

Molecular Pharmaceutics: Driving Advanced Therapeutic Delivery

Mateo Rojas*
Faculty of Bioengineering, Universidad de Chile, Santiago, Chile
*Corresponding Author : Mateo Rojas, Faculty of Bioengineering, Universidad de Chile, Santiago, Chile, Email: mrojas@uchilebio.cl

Received Date: May 01, 2025 / Published Date: May 29, 2025

Abstract

Molecular pharmaceutics plays a crucial role in optimizing drug delivery and therapeutic outcomes. It enhances therapeutic drug monitoring for personalized patient care, minimizing adverse effects, especially for narrow therapeutic window drugs. The field advances mRNA vaccine formulations through stable lipid nanoparticle systems, and addresses complex delivery challenges for biologics, nucleic acids in gene therapy, and CRISPR/Cas9 systems, ensuring targeted action. It also explores innovative strategies for oral delivery of peptides, proteins, and mRNA therapeutics, overcoming bioavailability barriers. Additionally, molecular pharmaceutics significantly contributes to designing advanced delivery systems for cancer immunotherapy, boosting efficacy and reducing toxicity. This multidisciplinary field is central to contemporary pharmaceutical innovation.

Citation: Rojas M (2025) Molecular Pharmaceutics: Driving Advanced Therapeutic Delivery. J Mol Pharm Org Process Res 13: 285.

Copyright: © 2025 Mateo Rojas This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.

Top Connection closed successfully.